Ratutrelvir

Overview

Ratutrelvir is a NF-κB p65 inhibitor. Ratutrelvir blocks the translocation of NF-κB p65 from the cytoplasm to the nucleus, reduces the phosphorylation levels of NF-κB p65 and IκBα , and inhibits the DNA-binding activity of NF-κB p65 . Ratutrelvir inhibits the migration and invasion abilities of breast cancer cells, and reduces their viability and colony-forming capacity. Ratutrelvir can be used for the research of luminal A breast cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > NF-κB | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-185344
• CAS No.: 2929236-94-0
• Molecular Formula: C27H32F3N5O4
• Molecular Weight: 547.57
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source